HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taylor, P. R. Articles by Botto, M. Search for Related Content PubMed PubMed Citation Articles by Taylor, P. R. Articles by Botto, M. Social Bookmarking                      What's this?

Vol. 273, Issue 3, 1699-1704, January 16, 1998

A Targeted Disruption of the Murine Complement Factor B Gene Resulting in Loss of Expression of Three Genes in Close Proximity, Factor B, C2, and D17H6S45

From the Rheumatology Section, Division of Medicine, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom

Factor B is a serine protease, essential for the function of the alternative pathway of complement activation. To study further the importance of the alternative pathway of complement activation in vivo and to help elucidate any additional functions of factor B or its activation fragments we developed, by homologous recombination in embryonic stem cells, mice with a disrupted factor B gene. Factor B-deficient mice produced no detectable factor B mRNA or protein and had no detectable factor B enzymatic activity or alternative pathway function in their serum. Further studies revealed that the two adjacent genes, complement component C2 and D17H6S45, had been down regulated as a result of the disruption. The down-regulation of C2 gene expression was sufficient to cause a complete loss of classical pathway function as determined by the failure of sera from the deficient mice to opsonize antibody-sensitized sheep erythrocytes and by impairment of immune complex processing in vivo. The resulting mouse is deficient in both factor B and C2, and hence the alternative and classical pathways of complement activation, and adds to the repertoire of models for studying the in vivo role of complement in the immune system.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. C. Walsh, T. Bourcier, K. Takahashi, L. Shi, M. N. Busche, R. P. Rother, S. D. Solomon, R. A. B. Ezekowitz, and G. L. Stahl Mannose-Binding Lectin Is a Regulator of Inflammation That Accompanies Myocardial Ischemia and Reperfusion Injury J. Immunol., July 1, 2005; 175(1): 541 - 546. [Abstract] [Full Text] [PDF]

				M. L. Hart, K. A. Ceonzo, L. A. Shaffer, K. Takahashi, R. P. Rother, W. R. Reenstra, J. A. Buras, and G. L. Stahl Gastrointestinal Ischemia-Reperfusion Injury Is Lectin Complement Pathway Dependent without Involving C1q J. Immunol., May 15, 2005; 174(10): 6373 - 6380. [Abstract] [Full Text] [PDF]

				S. Baalasubramanian, C. L. Harris, R. M. Donev, M. Mizuno, N. Omidvar, W.-C. Song, and B. P. Morgan CD59a Is the Primary Regulator of Membrane Attack Complex Assembly in the Mouse J. Immunol., September 15, 2004; 173(6): 3684 - 3692. [Abstract] [Full Text] [PDF]

				M. Windbichler, B. Echtenacher, T. Hehlgans, J. C. Jensenius, W. Schwaeble, and D. N. Mannel Involvement of the Lectin Pathway of Complement Activation in Antimicrobial Immune Defense during Experimental Septic Peritonitis Infect. Immun., September 1, 2004; 72(9): 5247 - 5252. [Abstract] [Full Text] [PDF]

				E. Saeland, G. Vidarsson, J. H. W. Leusen, E. van Garderen, M. H. Nahm, H. Vile-Weekhout, V. Walraven, A. M. Stemerding, J. S. Verbeek, G. T. Rijkers, et al. Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice J. Immunol., June 15, 2003; 170(12): 6158 - 6164. [Abstract] [Full Text] [PDF]

				I. Celik, C. Stover, M. Botto, S. Thiel, S. Tzima, D. Kunkel, M. Walport, W. Lorenz, and W. Schwaeble Role of the Classical Pathway of Complement Activation in Experimentally Induced Polymicrobial Peritonitis Infect. Immun., December 1, 2001; 69(12): 7304 - 7309. [Abstract] [Full Text] [PDF]

				N. A. Mabbott and M. E. Bruce The immunobiology of TSE diseases J. Gen. Virol., October 1, 2001; 82(10): 2307 - 2318. [Full Text] [PDF]

				A. P. Manderson, M. C. Pickering, M. Botto, M. J. Walport, and C. R. Parish Continual Low-Level Activation of the Classical Complement Pathway J. Exp. Med., September 10, 2001; 194(6): 747 - 756. [Abstract] [Full Text] [PDF]

				P. R. Taylor, E. Seixas, M. J. Walport, J. Langhorne, and M. Botto Complement Contributes to Protective Immunity against Reinfection by Plasmodium chabaudi chabaudi Parasites Infect. Immun., June 1, 2001; 69(6): 3853 - 3859. [Abstract] [Full Text] [PDF]

				M. G. Robson, H. T. Cook, M. Botto, P. R. Taylor, N. Busso, R. Salvi, C. D. Pusey, M. J. Walport, and K. A. Davies Accelerated Nephrotoxic Nephritis Is Exacerbated in C1q-Deficient Mice J. Immunol., June 1, 2001; 166(11): 6820 - 6828. [Abstract] [Full Text] [PDF]

				D. A. Mitchell, P. R. Taylor, H. T. Cook, J. Moss, A. E. Bygrave, M. J. Walport, and M. Botto Cutting Edge: C1q Protects Against the Development of Glomerulonephritis Independently of C3 Activation J. Immunol., May 15, 1999; 162(10): 5676 - 5679. [Abstract] [Full Text] [PDF]